Social and economic effects of body weight in the United States
- PMID: 8615344
- DOI: 10.1093/ajcn/63.3.466
Social and economic effects of body weight in the United States
Abstract
Given that overweight is clearly associated with increased risk of many major chronic diseases, the United States could have saved approximately $45.8 billion or 6.8% of health care expenditures in 1990 alone if obesity were prevented. The question then arises, economically and socially, what is a healthy body weight? Using a prevalence-based approach to cost of illness, we estimated the economic costs (1993 dollars) associated with illness at different strata of body mass indexes (BMIs, in kg/m2) and varying increments of weight gain to address the questions: At what body weight do we initiate preventive services? What are the direct costs associated with weight gain? Second, using the 1988 National Health Interview Survey (NHIS), we evaluated the marginal increase in certain social indexes reflective of functional impairment and morbidity (ie, restricted-activity days, bed days, and work-loss days) as well as physician visits associated with different strata of BMI. With respect to economic and social indexes, a healthy body weight appears to be a BMI < 25, and weight gain should be kept to < 5 kg throughout a lifetime.
Similar articles
-
Current estimates of the economic cost of obesity in the United States.Obes Res. 1998 Mar;6(2):97-106. doi: 10.1002/j.1550-8528.1998.tb00322.x. Obes Res. 1998. PMID: 9545015 Review.
-
Economic burden of obesity-related chronic diseases in Mainland China.Obes Rev. 2008 Mar;9 Suppl 1:62-7. doi: 10.1111/j.1467-789X.2007.00440.x. Obes Rev. 2008. PMID: 18307701
-
Lifetime health and economic consequences of obesity.Arch Intern Med. 1999 Oct 11;159(18):2177-83. doi: 10.1001/archinte.159.18.2177. Arch Intern Med. 1999. PMID: 10527295
-
The cost of obesity: the US perspective.Pharmacoeconomics. 1994;5(Suppl 1):34-7. doi: 10.2165/00019053-199400051-00007. Pharmacoeconomics. 1994. PMID: 10147247
-
Economic costs of obesity and inactivity.Med Sci Sports Exerc. 1999 Nov;31(11 Suppl):S663-7. doi: 10.1097/00005768-199911001-00026. Med Sci Sports Exerc. 1999. PMID: 10593542 Review.
Cited by
-
Microlaparoscopic-assisted vaginal hysterectomy in the morbidly obese patient.JSLS. 2004 Jul-Sep;8(3):229-33. JSLS. 2004. PMID: 15347109 Free PMC article.
-
Outcomes of pharmacological and surgical treatment for obesity.Pharmacoeconomics. 1998 Sep;14(3):269-83. doi: 10.2165/00019053-199814030-00004. Pharmacoeconomics. 1998. PMID: 10186466 Review.
-
Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.Obes Rev. 2011 Jan;12(1):50-61. doi: 10.1111/j.1467-789X.2009.00708.x. Obes Rev. 2011. PMID: 20059703 Free PMC article.
-
Metalloproteases and adipogenesis: a weighty subject.Am J Pathol. 2002 May;160(5):1551-4. doi: 10.1016/S0002-9440(10)61100-5. Am J Pathol. 2002. PMID: 12000705 Free PMC article. No abstract available.
-
The direct and indirect costs of both overweight and obesity: a systematic review.BMC Res Notes. 2014 Apr 16;7:242. doi: 10.1186/1756-0500-7-242. BMC Res Notes. 2014. PMID: 24739239 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical